Background illustration for clinical trials search

Paid Clinical Trials Everett

Discover 1,418 paid clinical trials in Everett, Washington. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of JNJ-78278343 in Combination With JNJ-95298177 for Treatment of Prostate Cancer

for
Prostatic Neoplasms
Location: Seattle WA, Cleveland OH, New York NY, Sarasota FL
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07082920

Phase1, Recruiting

Axatilimab for Sclerotic Chronic Graft-versus-Host Disease

for
Chronic Graft Versus Host Disease
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07011810

Phase2, Recruiting

Odronextamab for Relapsed and Refractory Large B-cell Lymphomas Before CAR-T

for
Recurrent Diffuse Large B-Cell Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06784726

Phase2, Recruiting

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

for
Non-Hodgkin Lymphoma Refractory/ Relapsed,
Location: Seattle WA, Duarte CA, St Louis MO, Nashville TN,
Sponsor: LTZ Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT07121946

Phase1, Recruiting

A Clinical Study of Intismeran Autogene (V940) and Pembrolizumab (MK-3475) in People With Melanoma (V940-012/INTerpath-012)

for
Malignant Melanoma
Location: Seattle WA, San Francisco CA, Springdale AR, Brampton,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06961006

Phase2, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

for
Breast Neoplasms, Triple Negative Breast Neoplasms,
Location: Seattle WA, Tacoma WA, Surrey, Vancouver, Tigard OR,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06966700

Phase3, Recruiting

Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors

for
Melanoma, Medullary Thyroid Cancer,
Location: Seattle WA, Tucson AZ
Sponsor: University of Arizona

Sex: All

Age: 18 - 70+

Code: NCT06814496

Phase1, Phase2, Recruiting

Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors

for
Pancreatic Neuroendocrine Tumor (pNET),
Location: Seattle WA, Portland OR, Vallejo CA, Salt Lake City UT,
Sponsor: Exelixis

Sex: All

Age: 18+

Code: NCT06943755

Phase2, Phase3, Recruiting

Combination Chemotherapy (FLAG-Ida) Followed Immediately by Reduced-Intensity Total Body Radiation Therapy and Donor Hematopoietic Cell Transplant for the Treatment of Adults Age 60 and Older With Newly Diagnosed Adverse-Risk Acute Myeloid Leukemia or Other High-Grade Myeloid Cancer

for
Acute Leukemia of Ambiguous Lineage, Acute Myeloid Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT07046078

Phase2, Recruiting

Pirtobrutinib and Mosunetuzumab for the Treatment of Relapsed/Refractory Grades 1-3A Follicular Lymphoma, PROMOTE-FL Trial

for
Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma,
Location: Seattle WA
Sponsor: University of Washington

Sex: All

Age: 18+

Code: NCT06948786

Phase2, Recruiting

A Study of BGB-B455 in Adults With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumor, Metastatic Solid Tumor
Location: Seattle WA, Sioux Falls SD, San Antonio TX,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06803680

Phase1, Recruiting

BGB-21447 (Bcl-2 Inhibitor) Combinations for Adults With Hormone-Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Metastatic Breast Cancer

for
Hormone-receptor-positive Breast Cancer,
Location: Seattle WA, Iowa City IA, Houston TX
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06756932

Phase1, Recruiting

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

for
AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL),
Location: Seattle WA, Portland OR, Palo Alto CA, Duarte CA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 18 - 66

Code: NCT06859424

Phase2, Recruiting

Chemotherapy (Decitabine in Combination With FLAG-Ida) and Total-Body Irradiation Followed by Donor Stem Cell Transplant for the Treatment of Adults With Myeloid Malignancies at High Risk of Relapse

for
Acute Myeloid Leukemia, Acute Undifferentiated Leukemia,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06928662

Phase1, Phase2, Recruiting

Development of Measures to Screen for Financial Hardship in Alzheimer's Disease and Dementia

for
Financial Hardship, Alzheimer's Disease (AD),
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06922188

Recruiting

ColoCare Study - Colorectal Cancer Cohort

for
Colorectal Cancer
Location: Seattle WA, Salt Lake City UT, Los Angeles CA,
Sponsor: University of Utah

Sex: All

Age: 18 - 70+

Code: NCT02328677

Recruiting

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for
Hematologic Malignancies, Inherited Disorders of Metabolism,
Location: Seattle WA, Portland OR, Sacramento CA,
Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All

Age: 0+

Code: NCT01351545

Recruiting

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

for
Hepatocellular Carcinoma, Liver Cancer, Adult, Liver Neoplasm,
Location: Seattle WA, Portland OR, Duarte CA, Dallas TX,
Sponsor: Eureka Therapeutics Inc.

Sex: All

Age: 18+

Code: NCT04864054

Phase1, Phase2, Recruiting

Sonrotoclax, Rituximab, and Zanubrutinib in Treating Participants With Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, and Mantle Cell Lymphoma

for
Chronic Lymphocytic Leukemia, Mantle Cell Lymphoma,
Location: Seattle WA
Sponsor: Fred Hutchinson Cancer Center

Sex: All

Age: 18+

Code: NCT06839053

Phase2, Recruiting

Testing the Use of Ado-Trastuzumab Emtansine Compared to the Usual Treatment (Chemotherapy With Docetaxel Plus Trastuzumab) or Trastuzumab Deruxtecan for Recurrent, Metastatic, or Unresectable HER2-Expressing Salivary Gland Cancers

for
Metastatic Salivary Gland Carcinoma,
Location: Seattle WA, Issaquah WA, Fruitland ID, Nampa ID,
Sponsor: NRG Oncology

Sex: All

Age: 18+

Code: NCT05408845

Phase2, Recruiting